AI Buyer Insights:

● Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

● Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

● Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

● Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

● Michelin, an e2open customer evaluated Oracle Transportation Management

● Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

● Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

● Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

● Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

● Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

● Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

● Michelin, an e2open customer evaluated Oracle Transportation Management

● Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

● Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Blossomhill Therapeutics Tech Stack and Enterprise Applications

IT Decision Makers and Key Stakeholders at Blossomhill Therapeutics

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Blossomhill Therapeutics Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Blossomhill Therapeutics IT executives and key decision makers. This section highlights Blossomhill Therapeutics's latest recorded technology evaluations, including Microsoft 365 Copilot for Generative AI Platforms on 2026-09-14. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Blossomhill Therapeutics digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
2026-09-14 Blossomhill Therapeutics Evaluated Microsoft Microsoft 365 Copilot Generative AI Platforms AI Development
FAQ - APPS RUN THE WORLD Blossomhill Therapeutics Technographics
Blossomhill Therapeutics is a Life Sciences organization based in United States, with around 45 employees and annual revenues of $1.0 million.
APPS RUN THE WORLD maintains an up-to-date database of Blossomhill Therapeutics’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Blossomhill Therapeutics’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Blossomhill Therapeutics technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.